PROQR THERAPEUTICS NV (PRQR)

NL0010872495 - Common Stock

2.62  -0.14 (-5.07%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
21.32M9.53M4.80M2.40M9.45M
Minority Interest Expense
N/A-384.00K-220.00K60.00K50.00K
Operating Expenses
47.98M41.38M69.52M59.59M51.82M
Research and Development
33.48M23.15M48.78M40.53M36.35M
Selling, General, and Administrative Expenses
14.50M15.72M18.22M16.73M13.12M
Operating Income
-26.66M-31.86M-64.72M-57.19M-42.37M
Interest Income/Expense
2.53M2.09M1.31M-4.37M-4.12M
Other Income/Expense
N/A0.00N/A510.00KN/A
Non Recurring Items
-92.00K1.87M-1.39MN/AN/A
Income Before Taxes
-24.13M-27.81M-64.80M-61.56M-46.49M
Income Tax
-192.00K-78.00K100.00K120.00K120.00K
Net Income
-23.94M-28.12M-65.11M-61.62M-46.57M
EBITDA
-23.85M-29.35M-62.20M-54.86M-40.01M
 
Per Share Data
EPS Diluted Total Ops
-0.29-0.35-0.91-0.96-0.93
Non GAAP EPS
-0.29-0.35-0.91-0.97-0.92
 
Statistics
Profit Margin
-112.31%-295.21%-1356.46%-2567.50%-492.80%
Operating Profit Margin
-125.06%-334.48%-1348.33%-2382.92%-448.36%

All data in EUR

Charts